Table I.
miR-217 expression | ||||
---|---|---|---|---|
Characteristics | No. of patients | Low | High | P-value |
No. of patients | 121 | 53 | 68 | |
Age, years | 0.14 | |||
<50 | 71 | 32 | 39 | |
≥50 | 50 | 21 | 29 | |
Gender | 0.10 | |||
Male | 69 | 28 | 41 | |
Female | 52 | 25 | 27 | |
MTD, cm | 0.08 | |||
<5 | 80 | 38 | 42 | |
≥5 | 41 | 15 | 26 | |
Tumor location | 0.11 | |||
Rectum | 57 | 27 | 30 | |
Colon | 64 | 26 | 38 | |
Depth of invasion | 0.14 | |||
T1/T2 | 38 | 18 | 20 | |
T3/T4 | 83 | 35 | 48 | |
Survival status | 0.01 | |||
Alive | 23 | 5 | 18 | |
Dead | 98 | 48 | 50 | |
TNM stage | 0.09 | |||
II | 49 | 24 | 25 | |
III/IV | 72 | 29 | 43 |
TNM, T category describes the primary tumor site; N category describes the regional lymph node involvement; M category describes the presence or otherwise of distant metastatic spread; MTD, mean tumor diameter; miR, microRNA.